The FDA must provide consistent and predictable regulatory frameworks if the U.S. is to maintain its leadership in gene ...

Ned Sharpless, a first-term Trump health official who has criticized vaccine policies championed by Robert F Kennedy Jr., is ...

Sen. Bill Cassidy (R-La.) finds himself in a unique position: scorned by President Trump and out of the running for reelection, but still in charge of the highly influential Senate health committee, ...

Replimune said it plans to resubmit its melanoma drug for approval following two earlier rejections. The move follows the departure of Food and Drug Administration Commissioner Marty Makary. Replimune ...

As the FDA adjusts to life without Marty Makary, M.D., Fierce has learned that the numerous policy reforms he put in motion are set to remain intact, including the controversial Commissioner’s ...

This is read by an automated voice. Please report any issues or inconsistencies here. ALBUQUERQUE — The Senate confirmed President Trump’s pick to oversee the management of a quarter-billion acres of ...

This editorial originally appeared in the Baltimore Sun: Even at the Johns Hopkins School of Medicine, you likely will not find a physician without opinions about one of its most prominent alumni, Dr.

Senate Republicans might advance the funding bill without a $1 billion provision for the Secret Service that would go toward ...

The lawsuit filed against President Trump’s $1.776 billion “anti-weaponization” fund has been assigned to a judge already on the president’s bad side. U.S. District Judge Richard Leon will be ...

PHOENIX -- Ignoring objections from one of their own with military experience, the Arizona Senate voted to confirm the pick of Gov. Katie Hobbs to head the Arizona National Guard. The voice vote came ...

WASHINGTON — Sen. Bill Cassidy’s loss in the Louisiana Republican primary over the weekend puts the future of the powerful Health, Education, Labor and Pensions Committee in flux. During his tenure as ...

The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of ...